Everything tagged "margins" across the TickerSpark archives.
Cintas posted record fiscal 2026 revenue and margin expansion, but the stock still trades at a premium multiple. The report rates CTAS a Buy only on pullbacks, with fair value set at $205.
KLA posted another strong quarter as AI, leading-edge foundry logic, and high-bandwidth memory lifted demand for its mission-critical process control tools. The stock still earns a Buy, though valuation is rich after a run of elite margins, recurring service revenue, and rising visibility into 2027.
Applied Materials is benefiting from AI-driven spending in leading-edge logic, DRAM, and advanced packaging, with record Q2 results and strong margin expansion. The stock still earns a Buy, but valuation is no longer cheap.
Lam Research is benefiting from AI-led demand in deposition, etch, and clean tools, with record revenue, expanding margins, and a growing installed-base services business. Valuation is rich, but the company’s operating leverage and memory/foundry exposure keep the stock attractive for disciplined buyers.
Owens Corning’s sharp move looks earned, not random. The market is finally paying up for a simpler building-products story that is still producing strong margins and cash in a weak housing backdrop.
Rivian’s R2 launch is finally moving from story stock fuel to an execution exam, and the market is reacting accordingly. A company with a negative 1.7% gross margin and fresh workforce cuts tied to profitability does not get the benefit of the doubt on a major volume ramp.
TSMC is not just riding the AI boom; it is one of the bottlenecks making that boom possible. When management says it will take a "very long time" to meet demand, that reads like scarcity power, and the numbers still back it up.
Graham has moved into a more durable growth phase, powered by record backlog, defense-heavy demand, and improving margins. But the stock already prices in much of that progress, leaving a Hold case despite strong operating momentum.
Workday's latest quarter gave software bulls exactly what they needed: proof that AI is showing up in product usage and margin expansion at the same time. The stock still has work to do after a brutal YTD drawdown, but this report made the disruption narrative a lot harder to sell.
Medline is growing at scale with strong customer retention and a deep med-surg distribution network, but margin pressure and a rich valuation keep the stock from looking cheap.
Fair Isaac is a high-margin compounder with dominant credit-scoring economics and growing software momentum. The stock looks constructive, but its premium valuation leaves little room for execution misses.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the GeneratorCancel anytime